{"nct_id":"NCT01610284","title":"Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2012-08-07","start_date_type":"ACTUAL","primary_completion_date":"2015-04-29","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}